Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GMED Globus Medical	$58.54 -0.5%	$62.57	$54.48 ▼ $94.93	$7.93B	1.2	1.12 million shs	1.46 million shs
ITGR Integer	$122.73 +0.7%	$120.29	$104.93 ▼ $146.36	$4.28B	0.98	382,951 shs	1.05 million shs
NUVA NuVasive	$39.75	$39.64	$35.17 ▼ $49.53	$2.08B	1.07	1.16 million shs	N/A
TFX Teleflex	$119.42 -0.1%	$124.41	$115.94 ▼ $249.91	$5.28B	1.1	627,870 shs	712,257 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GMED Globus Medical	0.00%	+1.28%	-0.35%	-19.25%	-13.98%
ITGR Integer	0.00%	+4.08%	+2.72%	+4.81%	+6.94%
NUVA NuVasive	0.00%	0.00%	0.00%	0.00%	0.00%
TFX Teleflex	0.00%	+1.18%	-2.31%	-13.31%	-40.26%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GMED Globus Medical	4.9343 of 5 stars	4.3	5.0	0.0	4.1	2.3	2.5	1.9
ITGR Integer	3.2999 of 5 stars	3.5	4.0	0.0	0.0	1.4	2.5	1.3
NUVA NuVasive	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	4.6382 of 5 stars	3.0	4.0	2.5	3.9	2.3	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GMED Globus Medical	2.62	Moderate Buy	$94.00	60.58% Upside
ITGR Integer	3.00	Buy	$145.00	18.15% Upside
NUVA NuVasive	0.00	N/A	N/A	N/A
TFX Teleflex	2.09	Hold	$164.63	37.85% Upside

Current Analyst Ratings Breakdown

Latest NUVA, GMED, TFX, and ITGR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/10/2025	GMED Globus Medical	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
5/27/2025	GMED Globus Medical	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
5/27/2025	GMED Globus Medical	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
5/22/2025	ITGR Integer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy	$133.00 ➝ $140.00
5/12/2025	GMED Globus Medical	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$80.00 ➝ $68.00
5/9/2025	GMED Globus Medical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$100.00 ➝ $80.00
5/5/2025	TFX Teleflex	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$140.00 ➝ $137.00
5/5/2025	TFX Teleflex	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$191.00 ➝ $173.00
5/2/2025	TFX Teleflex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$150.00 ➝ $145.00
5/2/2025	TFX Teleflex	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$146.00 ➝ $137.00
4/25/2025	ITGR Integer	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$140.00 ➝ $150.00

(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GMED Globus Medical	$2.52B	3.15	$6.65 per share	8.80	$30.40 per share	1.93
ITGR Integer	$1.72B	2.49	$8.92 per share	13.76	$48.27 per share	2.54
NUVA NuVasive	$1.23B	1.70	$4.96 per share	8.01	$17.02 per share	2.34
TFX Teleflex	$3.05B	1.73	$25.35 per share	4.71	$92.11 per share	1.30

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GMED Globus Medical	$102.98M	$1.34	43.68	14.53	1.71	7.39%	10.52%	8.56%	8/5/2025 (Estimated)
ITGR Integer	$119.90M	$2.11	58.16	18.46	1.05	4.38%	11.95%	6.04%	7/24/2025 (Estimated)
NUVA NuVasive	$40.41M	$0.50	79.50	15.35	N/A	2.32%	12.17%	4.88%	N/A
TFX Teleflex	$69.68M	$3.17	37.67	7.87	1.87	4.96%	14.73%	8.79%	7/30/2025 (Estimated)

Latest NUVA, GMED, TFX, and ITGR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/24/2025	Q2 2025	ITGR Integer	$1.57	N/A	N/A	N/A	$464.37 million	N/A
5/8/2025	Q1 2025	GMED Globus Medical	$0.74	$0.68	-$0.06	$0.54	$629.74 million	$598.12 million
5/1/2025	Q1 2025	TFX Teleflex	$2.88	$2.91	+$0.03	$2.07	$699.37 million	$700.67 million
4/24/2025	Q1 2025	ITGR Integer	$1.27	$1.31	+$0.04	-$0.66	$428.51 million	$437.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GMED Globus Medical	N/A	N/A	N/A	N/A	N/A
ITGR Integer	N/A	N/A	N/A	N/A	N/A
NUVA NuVasive	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.14%	N/A	42.90%	N/A

Latest NUVA, GMED, TFX, and ITGR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/12/2025	TFX Teleflex	quarterly	$0.34	1.09%	5/20/2025	5/20/2025	6/16/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GMED Globus Medical	N/A	4.45	2.72
ITGR Integer	0.78	3.40	2.14
NUVA NuVasive	0.50	1.25	0.65
TFX Teleflex	0.44	2.28	1.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GMED Globus Medical	95.16%
ITGR Integer	99.29%
NUVA NuVasive	N/A
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
GMED Globus Medical	18.51%
ITGR Integer	2.16%
NUVA NuVasive	0.53%
TFX Teleflex	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GMED Globus Medical	5,300	135.38 million	110.32 million	Optionable
ITGR Integer	11,000	34.89 million	34.14 million	Optionable
NUVA NuVasive	3,000	52.45 million	52.17 million	Optionable
TFX Teleflex	14,100	44.19 million	43.57 million	Optionable

NUVA, GMED, TFX, and ITGR Headlines

Recent News About These Companies

Teleflex (NYSE:TFX) Stock Rating Lowered by Wall Street Zen

1 hour ago | americanbankingnews.com

Teleflex (NYSE:TFX) Downgraded to "Hold" Rating by Wall Street Zen

1 hour ago | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Shares Sold by Marathon Asset Management Ltd

June 28 at 7:32 AM | marketbeat.com

Zacks Research Comments on Teleflex's Q2 Earnings (NYSE:TFX)

June 27 at 6:54 AM | marketbeat.com

Zacks Research Has Bearish Forecast for Teleflex Q2 Earnings

June 27 at 2:21 AM | americanbankingnews.com

5 Insightful Analyst Questions From Teleflex’s Q1 Earnings Call

June 26 at 8:15 AM | finance.yahoo.com

What is Zacks Research's Estimate for Teleflex Q2 Earnings?

June 26 at 6:34 AM | marketbeat.com

Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching

June 25, 2025 | finance.yahoo.com

Teleflex (NYSE:TFX) Reaches New 1-Year Low - What's Next?

June 23, 2025 | marketbeat.com

2,500 Shares in Teleflex Incorporated (NYSE:TFX) Acquired by Praxis Investment Management Inc.

June 23, 2025 | marketbeat.com

Teleflex (NYSE:TFX) Upgraded to "Buy" at Wall Street Zen

June 22, 2025 | americanbankingnews.com

Teleflex Incorporated (NYSE:TFX) Shares Bought by State of Alaska Department of Revenue

June 21, 2025 | marketbeat.com

Brokerages Set Teleflex Incorporated (NYSE:TFX) PT at $164.63

June 21, 2025 | americanbankingnews.com

Wall Street Zen Upgrades Teleflex (NYSE:TFX) to "Buy"

June 21, 2025 | marketbeat.com

Boston Trust Walden Corp Has $18.15 Million Stake in Teleflex Incorporated (NYSE:TFX)

June 20, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of "Hold" from Analysts

June 18, 2025 | marketbeat.com

Teleflex (NYSE:TFX) Sets New 12-Month Low - Time to Sell?

June 17, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Shares Sold by Assenagon Asset Management S.A.

June 17, 2025 | marketbeat.com

SG Americas Securities LLC Takes $1.37 Million Position in Teleflex Incorporated (NYSE:TFX)

June 17, 2025 | marketbeat.com

Mountain Pacific Investment Advisers LLC Reduces Stock Position in Teleflex Incorporated (NYSE:TFX)

June 16, 2025 | marketbeat.com

Teleflex Study Shows 70.5% Reduction in CLABSI with Antimicrobial CVCs

June 15, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUVA, GMED, TFX, and ITGR Company Descriptions

Globus Medical NYSE:GMED

$58.54 -0.28 (-0.48%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$58.54 0.00 (0.00%)

As of 06/27/2025 06:30 PM Eastern

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Integer NYSE:ITGR

$122.73 +0.86 (+0.70%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$122.57 -0.16 (-0.13%)

As of 06/27/2025 05:11 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

NuVasive NASDAQ:NUVA

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.

Teleflex NYSE:TFX

$119.42 -0.16 (-0.13%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$119.47 +0.05 (+0.04%)

As of 06/27/2025 04:27 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time